A Comparison of Surgical Preparations and Wound Infection Rates for Elective Cesarean Sections
Primary Purpose
Wound Infection
Status
Terminated
Phase
Phase 3
Locations
Canada
Study Type
Interventional
Intervention
povidone-iodine solution
chlorhexidine gluconate
Sponsored by
About this trial
This is an interventional treatment trial for Wound Infection focused on measuring infection, sepsis, povidone-iodine, chlorhexidine gluconate, fever, erythema, leukocytosis, drainage, vaginal discharge, elective cesarean section
Eligibility Criteria
Inclusion Criteria:
- Age >19 years
- Gestational age > 37 weeks
- Booked elective cesarean section
Exclusion Criteria:
- Gestational age < 37 weeks
- Premature rupture of membranes
- Onset of labor prior to procedure
- Evidence of maternal sepsis; maternal fever > 38.5C
- LSCS for emergency issues: non-reassuring fetal status, placental abruption, failed induction
Sites / Locations
- Women' s Health Centre, Eastern Health
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Active Comparator
Arm Label
A
B
Arm Description
povidone-iodine
chlorhexidine gluconate
Outcomes
Primary Outcome Measures
to determine the rate of wound infection using two standard wound preparations: povidone-iodine and chlorhexidine gluconate
Secondary Outcome Measures
readmission to hospital
extended length of admission
need for intravenous antibiotics
need for repeat procedure such as drainage
increased outpatient surveillance
Full Information
NCT ID
NCT00528008
First Posted
September 10, 2007
Last Updated
November 8, 2012
Sponsor
Memorial University of Newfoundland
Collaborators
Eastern Health
1. Study Identification
Unique Protocol Identification Number
NCT00528008
Brief Title
A Comparison of Surgical Preparations and Wound Infection Rates for Elective Cesarean Sections
Official Title
Povidone-iodine vs. Chlorhexidine Gluconate - A Comparison of Surgical Preparations and Wound Infection Rates for Elective Cesarean Sections
Study Type
Interventional
2. Study Status
Record Verification Date
November 2012
Overall Recruitment Status
Terminated
Why Stopped
Study was stopped following interim analysis.
Study Start Date
December 2007 (undefined)
Primary Completion Date
February 2010 (Actual)
Study Completion Date
February 2010 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Memorial University of Newfoundland
Collaborators
Eastern Health
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The purpose of this study is to find out if chlorhexidine gluconate solution is better at reducing the rate of wound infection after cesarean section compared to povidone-iodine.
Detailed Description
Wound infection is a universal potential morbidity to any type of surgery. Over the years many studies have been completed to evaluate ways to decrease this morbidity. Recent literature has looked at different types of surgical solutions used in pre-operative cleansing. Chlorhexidine and povidone-iodine are two standard surgical prep solutions used on a global scale. The most recent literature has shown that chlorhexidine has a decreased wound infection rate for longer surgeries. Cesarean section, as a surgical time, varies from 20 - 60 minutes. There has been no known literature regarding wound infection rates using these two solutions in elective cesarean sections. This trial will review the rates of wound infection using chlorhexidine and povidone-iodine during elective cesarean section and determine if there is any statistically significant difference between the two solutions. The results could potentially decrease wound infection rates, decrease morbidity, decrease hospital length of stay, and help to guide further surgical management.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Wound Infection
Keywords
infection, sepsis, povidone-iodine, chlorhexidine gluconate, fever, erythema, leukocytosis, drainage, vaginal discharge, elective cesarean section
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
268 (Actual)
8. Arms, Groups, and Interventions
Arm Title
A
Arm Type
Active Comparator
Arm Description
povidone-iodine
Arm Title
B
Arm Type
Active Comparator
Arm Description
chlorhexidine gluconate
Intervention Type
Other
Intervention Name(s)
povidone-iodine solution
Other Intervention Name(s)
Betadine, Povidone, Minidyne
Intervention Description
Abdominal surgical field cleaned with 5% povidone-iodine detergent scrub, detergent cleaned from surgical area with sterile water, and then painted with 1% povidone-iodine solution.
Intervention Type
Other
Intervention Name(s)
chlorhexidine gluconate
Other Intervention Name(s)
Dexidine, Avagard, Bactoshield
Intervention Description
Abdominal surgical field painted once using 2% chlorhexidine in 70% alcohol.
Primary Outcome Measure Information:
Title
to determine the rate of wound infection using two standard wound preparations: povidone-iodine and chlorhexidine gluconate
Time Frame
within 6 weeks following surgery
Secondary Outcome Measure Information:
Title
readmission to hospital
Time Frame
within 6 weeks following surgery
Title
extended length of admission
Time Frame
within 6 weeks following surgery
Title
need for intravenous antibiotics
Time Frame
within 6 weeks following surgery
Title
need for repeat procedure such as drainage
Time Frame
within 6 weeks following surgery
Title
increased outpatient surveillance
Time Frame
within 6 weeks following surgery
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
19 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Age >19 years
Gestational age > 37 weeks
Booked elective cesarean section
Exclusion Criteria:
Gestational age < 37 weeks
Premature rupture of membranes
Onset of labor prior to procedure
Evidence of maternal sepsis; maternal fever > 38.5C
LSCS for emergency issues: non-reassuring fetal status, placental abruption, failed induction
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Paula Mallaley, MD
Organizational Affiliation
Resident, Obstetrics and Gynecology, Memorial University of Newfoundland
Official's Role
Principal Investigator
Facility Information:
Facility Name
Women' s Health Centre, Eastern Health
City
St. John's
State/Province
Newfoundland and Labrador
ZIP/Postal Code
A1E 5K9
Country
Canada
12. IPD Sharing Statement
Learn more about this trial
A Comparison of Surgical Preparations and Wound Infection Rates for Elective Cesarean Sections
We'll reach out to this number within 24 hrs